Home » Topics » Regulatory » Patents

Patents
RSS

EA Pharma discovers novel MAdCAM antagonists

Aug. 29, 2017

BioCryst Pharmaceuticals divulges complement factor D inhibitors

Aug. 29, 2017

Epizyme patents PRMT inhibitors

Aug. 29, 2017

Roche discloses new DDR1 inhibitors

Aug. 28, 2017

AstraZeneca AB and Eolas Therapeutics patent orexin receptor antagonists

Aug. 28, 2017

Shenzhen Targetrx Biotechnology divulges novel CYP17A1 inhibitors

Aug. 28, 2017

Fochon Pharma and collaborators present ALK inhibitors

Aug. 28, 2017

Yangtze River Pharmaceutical Group and collaborator patent Nav1.7 channel blockers

Aug. 28, 2017

EA Pharma divulges new TRPA1 antagonists

Aug. 25, 2017

Savira, European Molecular Biology Laboratory discover novel compounds for influenza

Aug. 25, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...